

TEM image of SARS-CoV-2
The Virus : What is it?
COVID-19 is a viral respiratory illness caused by the SARS-CoV-2 coronavirus. Coronaviruses are fairly common in animals with six previously documented versions in humans with effects ranging from the “common cold” to more serious diseases such as the related SARS and MERS. SARS-CoV-2 is novel to humans and has become a significant threat as it spread faster than the immune system was able to develop a response to it.
The virus itself is a simple structure, consisting of an RNA ‘payload’ inside a lipid (‘fatty’) envelope approx. 125nm in dia. with external protein spikes to attach to and enter a host cell for replication.
Mutations have the potential to invalidate a vaccine and prolong the pandemic but to date the mutation rate for SARS-CoV-2 has been about half what is known for the influenza virus.
The Virus : Infection Dynamics
Transmission: Humans are the rats in this plague. Transmission of COVID-19 is primarily human-human (H2H) with the virus being aspirated by an infected human in various sizes of liquid droplets. Gravity causes the larger, heavier drops (>5um in dia) to fall on nearby surfaces where the virus can be transferred by physical contact and subsequent self-touching (eyes, nose, mouth). The virus can remain active on surfaces anywhere from hours to days depending on the surface material.
Smaller droplets (aersols, <20um) remain suspended in the air and can travel much further (8m+) as in a sneeze or via active ventilation in a conditioned space and remain for up to 16 hrs.. They are more likely to make it past leaks in loose fitting masks and be inhaled deeper into the lungs. Airborne transmission is now understood as the main mode of transmission and a pivotal consideration for any policy on re-opening the economy.
Level of Exposure: The best guess is a few hundred viruses is sufficient to infect a person.
Asymptotic carriers are a major concern as infected carriers without symptoms are less likely to adhere to recommended isolation practices, increasing the risk of spreading the disease. Surprisingly high numbers of asymptotic carriers have been reported in studies ( >80% !! ) which has some upside as it possibly indicates a higher level of immunity than expected, perhaps as the result of T-cells kicking in from a similar previous infection. There is a lot more to learn.
The Virus : Disease Cycle
Symptoms emerge anywhere from 3-14 days after infection.
Symptoms generally run for 7-14 days but can last much longer. People may experience something like a “hangover” effect or presistent “dry cough” but feel well enough to resume normal activities.
The issue is the length of time an infected person is contagious. It can start 2-3 days before symptoms appear (pre-symptomatic transmission) and persist for 10-14 days after symptoms develop, but have been shown to last as long as 37 days in some cases. Current quarantine protocols of 14 days are felt to be best practice.
And of course the issue with asymptotic carriers as previously mentioned.
The Virus : Historical Context
Spanish Flu 1918-1919 (H1N1)
WW 550M cases / 17-50M deaths
US 30M cases / 675,000 deaths (CDC, 2020)
Four waves were documented. which should be a consideration for the current pandemic
The high mortality rates in 20-40 yr olds could be attributed to work place mobility / interaction (highlights impact of H2H transmission).
Control efforts worldwide were applied unevenly and limited to non-pharmaceutical interventions such as isolation, quarantine, proactive personal hygiene, use of disinfectants and limitations of public gatherings.
SARS 2002-2004
WW 8098 cases / 774 deaths (WHO, 2020)
MERS 2012-2014
WW 2494 cases / 858 deaths (WHO, 2019-11)
COVID-19 2019 - ?
WW 17,889,134 cases / 686,145 deaths
(WHO, 2020-08-03)
US 4,582,276 cases / 153,757 deaths
(WHO, 2020-08-03)
The daily headlines continue to highlight the disruption and impact of the current pandemic. It’s not over yet and we’re heading into the fall which has treditionally seen an increase in similar/related illnesses.
The Virus :
What’s different?
Flu-like viruses including the coronavirus are not completely unknown in humans but the velocity and scope of this pandemic are highlighting key differences from what is known to epidemiologists.
It is new to humans. The immune system takes time to develop a response. SARS-C0V-2 is different enough that there isn’t an existing “blueprint” to mount a defense.
There is some promising news with T-cells, possibly as the result of previous vaccines.
It is deceptive. It has the ability to block the production of interferons which serve as a warning signal to the immune system. You can be infected and not feel it. The number of asymptotic carriers has been surprisingly high.
It peaks about a day before you feel sick. A highly contagious person could be spreading the disease without knowing it.
It does peculiar things experts never would have expected.
It causes deadly blood clots and corrupts lung cells into malfunctioning clumps (syncytia).
It can kick the immune system into overdrive causing runaway inflammation.
It has a strong association with obesity which hasn't been seen with other viral infections.
Residual health concerns have been noted for lungs, heart, brain, kidneys, etc.
It spreads in hot weather.
So far, the virus doesn’t seem to be playing by the rules when it comes to traditional immunity theory.
Scientists have discovered patients who had recovered from infection, but mysteriously didn’t develop any antibodies.
There is growing doubt about how long people who have been infected with SARS-CoV-2 remain immune to the disease.
There is some evidence to suggest that while antibodies can be detected in patients who have recovered from a severe case of COVID-19 for at least three months, a growing number of studies that show in milder cases the antibodies appear to rapidly decline from around three months after infection.
Although rare, there is at least one documented case where it might be possible to get it twice.
…
“I can promise you that over the next two years, we’ll learn a lot of things that we wish we’d known now that we are going to learn as we move forward.” (Offit, HG 2020)
The Virus : Outlook
As of 2020-08-10, the pandemic is still very much a major issue with a second wave rolling in the US as a result of uneven compliance with recommended best practices for isolation. A third wave is anticipated in the fall as people head indoors for colder weather. There are three general scenarios.
The pandemic will run its 'natural' course as the number of susceptible subjects falls. The manifestation of herd immunity..
BUT this will come at a cost in human lives. AND we don't know if we can only get it once or develop a durable immune response like measles, smallpox, or how long that might last.
COVID-19 becomes a part of the "new normal", such as the influenza virus and leads to seasonal flu cycles
BUT Covid-19 is more severe than the 'common" flu and likely to increase stress on the health care system if this is becomes the case.
Vaccine + a global innoculation program
BUT not a quick fix. Availbility + deployment logistics are key factors and will vary from country to country
AND quite costly in terms of time and $ to develop, $/person, and durability still TBD.
BUT could work, with results something like smallpox (viral infection)
BUT if no vaccine is available, it could take a very long time to return to business as usual
And what about the next one...?
“The unpredictable nature of the coronavirus is making it impossible for officials to say definitively that…”
The global case for following recommended protocals.
Regional evidence to support the case for compliance.
The US re-opening before a drop in the rate of new cases.
Updates as a third wave emerges around the globe.
